Cargando…

Improving the therapeutic index of two alkylating agents.

Detalles Bibliográficos
Autores principales:	Millar, J. L., Clutterbuck, R. D., Smith, I. E.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1980
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010424/ https://www.ncbi.nlm.nih.gov/pubmed/7426350

Ejemplares similares

Enzyme activated alkylating agents.
por: Ball, C. R., et al.
Publicado: (1973)

Urinary markers for exposures to alkylating or nitrosating agents.
por: Wishnok, J S, et al.
Publicado: (1993)

Prevention of acute deaths in mice after very high dose cyclophosphamide by divided dose schedule.
por: Evans, B. D., et al.
Publicado: (1984)

Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes.
por: Babbage, J. W., et al.
Publicado: (1982)

Proceedings: Alkylating agents as industrial carcinogens.
por: Munn, A.
Publicado: (1975)

Ablation of murine jejunal crypts by alkylating agents.
por: Moore, J. V.
Publicado: (1979)

L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
por: Warrington, R. C., et al.
Publicado: (1989)

Failure of high doses of alpha interferon to affect the growth of human carcinoma, melanoma, and myeloid leukaemia xenografts.
por: Clutterbuck, R. D., et al.
Publicado: (1983)

Alcohols as Alkylating Agents in the Cation‐Induced Formation of Nitrogen Heterocycles
por: Cox, Lydia, et al.
Publicado: (2022)

The response of human myeloid leukaemia xenografts to human recombinant tumour necrosis factor.
por: Clutterbuck, R. D., et al.
Publicado: (1989)

Urinary markers for measuring exposure to endogenous and exogenous alkylating agents and precursors.
por: Shuker, D E, et al.
Publicado: (1993)

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
por: Strobel, Hannah, et al.
Publicado: (2019)

Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents
por: Zamperini, C., et al.
Publicado: (2017)

3-methyladenine-DNA-glycosylase and O6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines.
por: Damia, G., et al.
Publicado: (1996)

In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
por: Siemann, D. W., et al.
Publicado: (1993)

Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes
por: Tran, Thai Q., et al.
Publicado: (2017)

Alkylating anticancer agents and their relations to microRNAs
por: Biersack, Bernhard
Publicado: (2019)

Polyphenols enhance the activity of alkylating agents in leukaemia cell lines
por: Mahbub, Amani A., et al.
Publicado: (2019)

The Nanostructure of Alkyl-Sulfonate Ionic Liquids: Two 1-Alkyl-3-methylimidazolium Alkyl-Sulfonate Homologous Series
por: Marques, Hugo, et al.
Publicado: (2023)

Self-Assembled Alkylated Polyamine Analogs as Supramolecular Anticancer Agents
por: Sil, Diptesh, et al.
Publicado: (2022)

PM00104 (Zalypsis(®)): A Marine Derived Alkylating Agent
por: Petek, Bradley J., et al.
Publicado: (2014)

Re-Directing an Alkylating Agent to Mitochondria Alters Drug Target and Cell Death Mechanism
por: Mourtada, Rida, et al.
Publicado: (2013)

Dose-dependent spatiotemporal responses of mammalian cells to an alkylating agent
por: Rancourt, Ann, et al.
Publicado: (2019)

Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
por: Egea, Javier, et al.
Publicado: (2022)

Alcohols as alkylating agents in heteroarene C–H functionalization
por: Jin, Jian, et al.
Publicado: (2015)

DNA Damage Induced by Alkylating Agents and Repair Pathways
por: Kondo, Natsuko, et al.
Publicado: (2010)

Epidermal growth factor (hEGF) has no effect on murine intestine epithelial damage and regeneration after melphalan.
por: Robinson, B. A., et al.
Publicado: (1985)

Effects of verapamil and alcohol on blood flow, melphalan uptake and cytotoxicity, in murine fibrosarcomas and human melanoma xenografts.
por: Robinson, B. A., et al.
Publicado: (1986)

Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow.
por: Robinson, B. A., et al.
Publicado: (1985)

Alkylboronic acids as alkylating agents: photoredox-catalyzed alkylation reactions assisted by K(3)PO(4)
por: Yue, Fuyang, et al.
Publicado: (2022)

Proceedings: A comparison of chemical and microbiological methods for estimating alkylating agent concentration.
por: Toogood, S. M., et al.
Publicado: (1974)

Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
por: Brown, J. M., et al.
Publicado: (1982)

DNA direct reversal repair and alkylating agent drug resistance
por: Gutierrez, Roberto, et al.
Publicado: (2021)

Alkyl Gallates as Potential Antibiofilm Agents: A Review
por: Rayan, Mahmoud, et al.
Publicado: (2023)

Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.
por: Berman, R., et al.
Publicado: (1985)

DNA stretching in the nucleosome facilitates alkylation by an intercalating antitumour agent
por: Davey, Gabriela E., et al.
Publicado: (2010)

Decreased spermatogonial quantity in prepubertal boys with leukaemia treated with alkylating agents
por: Poganitsch-Korhonen, M, et al.
Publicado: (2017)

Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours
por: Hussein, D, et al.
Publicado: (2009)

Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
por: McNally, N. J., et al.
Publicado: (1983)

Nearest neighbor affects G:C to A:T transitions induced by alkylating agents.
por: Glickman, B W, et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_3ibmmlhs7lg8a80libapicdhlo